+39 02 610346.1 - info@newron.com

Latest press releases

  • 15May
    Zambon Launches Xadago® (Safinamide) For Patients With Mid- To Late-Stage Parkinson’s Disease In Germany

     

  • 30Apr
    Newron Completes CHF24.3M/US$25.5M in Private Placement from Leading EU and US Investors

     

  • 24Mar
    Newron Shareholders Authorize Allocation of Additional Shares to Support Multiple Clinical Programs

     

  • 4Mar
    Newron to Present at the 27th Annual ROTH Conference

  • 4Mar
    Newron Pharmaceuticals reports 2014 financial results ▪ Board approves agenda for AGM on March 24, 2015

       

  • 2Mar
    Xadago® (safinamide) New Drug Application (NDA) Accepted for Filing by the U.S. Food and Drug Administration (FDA)

      

View All

Newron share price

Events

  • 1Jun
    Jefferies 2015 Healthcare Conference

    June 1-4, 2015 - Grand Hyatt, New York - USA

  • 20May
    Bio€quity Europe

    May 19-20, 2015 - InterContinental Vienna Hotel, Vienna - Austria

  • 4May
    DVFA Frühjahrskonferenz 2015

    May 4-6, 2015 - DVFA Center, Frankfurt - Germany

View Event Calendar